European Urology Supplements

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?
European Urology Supplements - Tập 6 - Trang 460-466 - 2007
François Desgrandchamps
Overactive Bladder (OAB): What We Thought We Knew and What We Know Today
European Urology Supplements - Tập 1 - Trang 3-10 - 2002
William D Steers
Combination of the indoleamine 2,3-dioxygenase 1 inhibitor (IDO1i) BMS-986205 with nivolumab (nivo): Updated safety across all tumors and efficacy in advanced bladder cancer (advBC) by patient (pt) subgroup
European Urology Supplements - Tập 18 Số 1 - Trang e1509-e1510 - 2019
Víctor Moreno, Jason J. Luke, Karen A. Gelmon, Anthony M. Joshua, A Varga, Jayesh Desai, B. Markman, Carlos Gomez‐Roca, Filippo de Braud, Shreya Patel, Matteo S. Carlino, Lillian L. Siu, Giuseppe Curigliano, Z. Liu, Yuji Ishii, Megan Wind‐Rotolo, Paul Basciano, Alex Azrilevich, Josep Tabernero
Clinical Endpoints for Assessing Bisphosphonate Efficacy in the Prevention of Skeletal Complications of Bone Metastases
European Urology Supplements - Tập 3 - Trang 34-39 - 2004
Pierre P. Major, Richard J. Cook
Resection of Renal Cell Cancer Metastases: Where Do We Stand in 2008?
European Urology Supplements - Tập 7 - Trang 436-442 - 2008
Mirja Ruutu, Petri Bono, Kimmo Taari
The Role of Urologists in the Management of Hormone-Refractory Prostate Cancer
European Urology Supplements - Tập 1 - Trang 24-28 - 2002
Karl Pummer
LUTS: A Risk Factor for Sexual Dysfunction in the BPH Patient
European Urology Supplements - Tập 2 - Trang 3-8 - 2003
Ignacio Moncada
Anatomic Extent of Pelvic Lymphadenectomy in Bladder Cancer
European Urology Supplements - Tập 9 - Trang 419-423 - 2010
Axel Heidenreich, David Pfister
Tổng số: 289   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10